Schizophrenia-associated genetic variants in ion channels exert pleiotropic effects on neuronal and cardiac excitability, providing a potential mechanistic link for cardiac comorbidities in schizophrenia.
Answers are grounded in this paper and cite their sources.
May link schizophrenia GWAS variants to cardiac cell dysfunction; leaves open causal role in patients.
Schizophrenia patients have an increased risk of cardiac dysfunction. A possible factor underlying this comorbidity are the common variants in the large set of genes that have recently been discovered in genome-wide association studies (GWASs) as risk genes of schizophrenia. Many of these genes control the cell electrogenesis and calcium homeostasis. We applied biophysically detailed models of layer V pyramidal cells and sinoatrial node cells to study the contribution of schizophrenia-associated genes on cellular excitability. By including data from functional genomics literature to simulate the effects of common variants of these genes, we showed that variants of voltage-gated Na + channel or hyperpolarization-activated cation channel-encoding genes cause qualitatively similar effects on layer V pyramidal cell and sinoatrial node cell excitability. By contrast, variants of Ca 2+ channel or transporter-encoding genes mostly have opposite effects on cellular excitability in the two cell types. We also show that the variants may crucially affect the propagation of the cardiac action potential in the sinus node. These results may help explain some of the cardiac comorbidity in schizophrenia, and may facilitate generation of effective antipsychotic medications without cardiac side-effects such as arrhythmia.
No takes yet. Share an insight, caveat, or question.
Mäki‐Marttunen et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: